Indian Diagnostic Market Outlook to 2017
The Indian Diagnostics Equipment Market has been witnessing burgeoning growth in the last few years. The rise in ageing population leading to increased demand for diagnostic services, growing awareness and interest in healthcare, and increased prevalence of diseases have all led to technological advancements in terms of automation and higher efficiency systems.
According to RNCOS’ report, “Indian Diagnostic Market Outlook to 2017”, the diagnostics equipment market, which is divided into In vitro Diagnostic Equipment and Diagnostic Imaging Equipment will grow at a CAGR of 18% over the period 2012-2017. The report provides an insight into the various trends that will shape the market in the coming years. It elaborates on the role that public-private partnerships, e-health points, and rise in automation will play in the growth of the market.
The report divides the In vitro diagnostics equipment market into different segments such as Biochemistry, Hematology, Immunochemistry, Coagulation, Urinalysis and Molecular Diagnostics. These segments have then been studied in terms of major tests and mechanisms, market outlook till 2017 and key players. On the similar lines, diagnostics imaging market has been divided into MRI, Ultrasound, X-Ray, CT and Nuclear Imaging segments.
The diagnostic lab services have been witnessing an increase in the number laboratory tests being outsourced to India. The coming years will see a rise in the share of the organized players in the diagnostic services market thereby, increasing the quality of results produced.
The report also discusses the regulatory environment in India with respect to diagnostic products. It talks about the various licenses and certification required by manufacturers and service providers and also touches upon the intellectual property aspect of diagnostic products.
At the end, the competitive scenario has been analyzed in terms of manufacturers and service providers, where a strength-and-weakness analysis has been performed to compare the players. There’s also a discussion about the recent activities of key players to depict an objective picture of the industry to clients to help them make sound investment decisions.
According to RNCOS’ report, “Indian Diagnostic Market Outlook to 2017”, the diagnostics equipment market, which is divided into In vitro Diagnostic Equipment and Diagnostic Imaging Equipment will grow at a CAGR of 18% over the period 2012-2017. The report provides an insight into the various trends that will shape the market in the coming years. It elaborates on the role that public-private partnerships, e-health points, and rise in automation will play in the growth of the market.
The report divides the In vitro diagnostics equipment market into different segments such as Biochemistry, Hematology, Immunochemistry, Coagulation, Urinalysis and Molecular Diagnostics. These segments have then been studied in terms of major tests and mechanisms, market outlook till 2017 and key players. On the similar lines, diagnostics imaging market has been divided into MRI, Ultrasound, X-Ray, CT and Nuclear Imaging segments.
The diagnostic lab services have been witnessing an increase in the number laboratory tests being outsourced to India. The coming years will see a rise in the share of the organized players in the diagnostic services market thereby, increasing the quality of results produced.
The report also discusses the regulatory environment in India with respect to diagnostic products. It talks about the various licenses and certification required by manufacturers and service providers and also touches upon the intellectual property aspect of diagnostic products.
At the end, the competitive scenario has been analyzed in terms of manufacturers and service providers, where a strength-and-weakness analysis has been performed to compare the players. There’s also a discussion about the recent activities of key players to depict an objective picture of the industry to clients to help them make sound investment decisions.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. MARKET TRENDS
3.1 Rise of Public-Private Partnership in Indian Diagnostic Market
3.2 E-Health Points: Transforming Rural Health Care
3.3 Rapidly Rising Technological Advancement and Automation
4. DISEASE PREVALENCE: ANALYSIS
4.1 Cardiovascular Diseases
4.2 Diabetes
4.3 Cancer
4.4 HIV/AIDS
4.5 Communicable Diseases
5. DIAGNOSTICS EQUIPMENT MARKET OUTLOOK TO 2017
5.1 IVD Equipment Market
5.2 Diagnostics Imaging Equipment Market
6. IVD EQUIPMENT MARKET SEGMENTATION
6.1 Biochemistry
6.1.1 Major Tests and Mechanism
6.1.2 Current and Future Market Outlook
6.1.3 Key Players
6.2 Hematology
6.2.1 Major Tests and Mechanism
6.2.2 Current and Future Market Outlook
6.2.3 Key Players
6.3 Immunochemistry
6.3.1 Major Tests and Mechanism
6.3.2 Current and Future Market Outlook
6.3.3 Key Players
6.4 Microbiology
6.4.1 Major Tests and Mechanism
6.4.2 Current and Future Market Outlook
6.4.3 Key Players
6.5 Coagulation
6.5.1 Major Tests and Mechanism
6.5.2 Current and Future Market Outlook
6.5.3 Key Players
6.6 Urinalysis
6.6.1 Major Tests and Mechanism
6.6.2 Current and Future Market Outlook
6.6.3 Key Players
6.7 Molecular Diagnostics
6.7.1 Major Tests and Mechanism
6.7.2 Current and Future Market Outlook
6.7.3 Key Players
7. DIAGNOSTIC IMAGING EQUIPMENT MARKET SEGMENTATION
7.1 MRI Systems
7.1.1 Test Mechanism
7.1.2 Current and Future Market Outlook
7.1.3 Key Players
7.2 Ultrasound Systems
7.2.1 Test Mechanism
7.2.2 Current and Future Market Outlook
7.2.3 Key Players
7.3 X-ray Systems
7.3.1 Test Mechanism
7.3.2 Current and Future Market Outlook
7.3.3 Key Players
7.4 Computed Tomography (CT) Systems
7.4.1 Test Mechanism
7.4.2 Current and Future Market Outlook
7.5 Nuclear Imaging Systems
7.5.1 Test Mechanism
7.5.2 Current and Future Market Outlook
8. LAB SERVICES MARKET OUTLOOK TO 2017
9. REGULATORY ENVIRONMENT
10. KEY PLAYERS
10.1 Manufacturers
10.1.1 Roche Holding Ltd.
10.1.2 Beckman Coulter
10.1.3 Abbott Laboratories
10.1.4 Siemens
10.1.5 Span Diagnostics Limited
10.1.6 Transasia
10.2 Service Providers
10.2.1 Super Religare Laboratories
10.2.2 Dr. Lal Path Labs
10.2.3 Metropolis Health Services
10.2.4 Thyrocare Technologies Limited
2. RESEARCH METHODOLOGY
3. MARKET TRENDS
3.1 Rise of Public-Private Partnership in Indian Diagnostic Market
3.2 E-Health Points: Transforming Rural Health Care
3.3 Rapidly Rising Technological Advancement and Automation
4. DISEASE PREVALENCE: ANALYSIS
4.1 Cardiovascular Diseases
4.2 Diabetes
4.3 Cancer
4.4 HIV/AIDS
4.5 Communicable Diseases
5. DIAGNOSTICS EQUIPMENT MARKET OUTLOOK TO 2017
5.1 IVD Equipment Market
5.2 Diagnostics Imaging Equipment Market
6. IVD EQUIPMENT MARKET SEGMENTATION
6.1 Biochemistry
6.1.1 Major Tests and Mechanism
6.1.2 Current and Future Market Outlook
6.1.3 Key Players
6.2 Hematology
6.2.1 Major Tests and Mechanism
6.2.2 Current and Future Market Outlook
6.2.3 Key Players
6.3 Immunochemistry
6.3.1 Major Tests and Mechanism
6.3.2 Current and Future Market Outlook
6.3.3 Key Players
6.4 Microbiology
6.4.1 Major Tests and Mechanism
6.4.2 Current and Future Market Outlook
6.4.3 Key Players
6.5 Coagulation
6.5.1 Major Tests and Mechanism
6.5.2 Current and Future Market Outlook
6.5.3 Key Players
6.6 Urinalysis
6.6.1 Major Tests and Mechanism
6.6.2 Current and Future Market Outlook
6.6.3 Key Players
6.7 Molecular Diagnostics
6.7.1 Major Tests and Mechanism
6.7.2 Current and Future Market Outlook
6.7.3 Key Players
7. DIAGNOSTIC IMAGING EQUIPMENT MARKET SEGMENTATION
7.1 MRI Systems
7.1.1 Test Mechanism
7.1.2 Current and Future Market Outlook
7.1.3 Key Players
7.2 Ultrasound Systems
7.2.1 Test Mechanism
7.2.2 Current and Future Market Outlook
7.2.3 Key Players
7.3 X-ray Systems
7.3.1 Test Mechanism
7.3.2 Current and Future Market Outlook
7.3.3 Key Players
7.4 Computed Tomography (CT) Systems
7.4.1 Test Mechanism
7.4.2 Current and Future Market Outlook
7.5 Nuclear Imaging Systems
7.5.1 Test Mechanism
7.5.2 Current and Future Market Outlook
8. LAB SERVICES MARKET OUTLOOK TO 2017
9. REGULATORY ENVIRONMENT
10. KEY PLAYERS
10.1 Manufacturers
10.1.1 Roche Holding Ltd.
10.1.2 Beckman Coulter
10.1.3 Abbott Laboratories
10.1.4 Siemens
10.1.5 Span Diagnostics Limited
10.1.6 Transasia
10.2 Service Providers
10.2.1 Super Religare Laboratories
10.2.2 Dr. Lal Path Labs
10.2.3 Metropolis Health Services
10.2.4 Thyrocare Technologies Limited
LIST OF FIGURES:
Figure 4-1: Number of Coronary Heart Disease Cases (Million), 2005 & 2015
Figure 4-2: Number of Diabetes Cases (Million), 2012 & 2030
Figure 4-3: Number of Cancer Incidences (‘000), 2010 & 2020
Figure 5-1: Diagnostics Equipment Market (Billion INR), 2012-2017
Figure 5-2: IVD Equipment Market (Billion INR), 2012-2017
Figure 5-3: IVD Equipment Market by Segment (%), 2012
Figure 5-4: Diagnostics Imaging Equipment Market (Billion INR), 2012-2017
Figure 5-5: Diagnostics Imaging Equipment Market by Segment (%), 2012
Figure 6-1: Biochemistry Market (Billion INR), 2012-2017
Figure 6-2: Biochemistry Instruments Market by Segment (%), 2012
Figure 6-3: Hematology Market (Billion INR), 2012-2017
Figure 6-4: Hematology Instruments Market by Segment (%), 2012
Figure 6-5: Immunochemistry Market (Billion INR), 2012-2017
Figure 6-6: Immunochemistry Market by Segment (%), 2012
Figure 6-7: Microbiology Market (Billion INR), 2012-2017
Figure 6-8: Microbiology Instruments Market by Segment (%), 2011
Figure 6-9: Coagulation Market (Million INR), 2012-2017
Figure 6-10: Coagulation Instruments Market by Segment (%), 2012
Figure 6-11: Urinalysis Market (Million INR), 2012-2017
Figure 6-12: Urinalysis Instruments Market by Segment (%), 2012
Figure 6-13: Molecular Diagnostics Market (Million INR), 2012-2017
Figure 6-14: Molecular Diagnostics Instruments Market by Segment (%), 2012
Figure 7-1: MRI Equipment Market (Billion INR), 2012-2017
Figure 7-2: MRI Equipment Market by Segment (%), 2012
Figure 7-3: Ultrasound Equipment Market (Billion INR), 2012-2017
Figure 7-4: Ultrasound Equipment Market by Segment (%), 2012
Figure 7-5: X-ray Equipment Market (Billion INR), 2012-2017
Figure 7-6: X-ray Equipment Market by Segment (%), 2012
Figure 7-7: X-ray Equipments Market by Vertical (%), 2010
Figure 7-8: CT Scanners Market (Billion INR), 2012-2017
Figure 7-9: CT Scanners Market by Segment (%), 2012
Figure 7-10: Nuclear Imaging Equipment Market (Billion INR), 2012-2017
Figure 7-11: Nuclear Imaging Equipment Market by Segment (%), 2012
Figure 8-1: Lab Services Market (Billion INR), 2012-2017
Figure 8-2: Share of Pathology and Imaging Services in Lab Services Market (2012)
Figure 10-1: Roche - Share of Diagnostics in Total Revenue (2012)
Figure 10-2: Roche - Revenue Breakup of Diagnostics by Segment (%), 2012
Figure 10-3: Beckman Coulter - Share of Clinical Diagnostics in Total Revenue (2010)
Figure 10-4: Beckman Coulter - Revenue Breakup of Clinical Diagnostics by Segment (%), 2010
Figure 10-5: Abbott - Revenue Breakup by Business Division (%), 2012
Figure 10-6: Siemens - Revenue Breakup by Business Division (%), 2012
Figure 4-1: Number of Coronary Heart Disease Cases (Million), 2005 & 2015
Figure 4-2: Number of Diabetes Cases (Million), 2012 & 2030
Figure 4-3: Number of Cancer Incidences (‘000), 2010 & 2020
Figure 5-1: Diagnostics Equipment Market (Billion INR), 2012-2017
Figure 5-2: IVD Equipment Market (Billion INR), 2012-2017
Figure 5-3: IVD Equipment Market by Segment (%), 2012
Figure 5-4: Diagnostics Imaging Equipment Market (Billion INR), 2012-2017
Figure 5-5: Diagnostics Imaging Equipment Market by Segment (%), 2012
Figure 6-1: Biochemistry Market (Billion INR), 2012-2017
Figure 6-2: Biochemistry Instruments Market by Segment (%), 2012
Figure 6-3: Hematology Market (Billion INR), 2012-2017
Figure 6-4: Hematology Instruments Market by Segment (%), 2012
Figure 6-5: Immunochemistry Market (Billion INR), 2012-2017
Figure 6-6: Immunochemistry Market by Segment (%), 2012
Figure 6-7: Microbiology Market (Billion INR), 2012-2017
Figure 6-8: Microbiology Instruments Market by Segment (%), 2011
Figure 6-9: Coagulation Market (Million INR), 2012-2017
Figure 6-10: Coagulation Instruments Market by Segment (%), 2012
Figure 6-11: Urinalysis Market (Million INR), 2012-2017
Figure 6-12: Urinalysis Instruments Market by Segment (%), 2012
Figure 6-13: Molecular Diagnostics Market (Million INR), 2012-2017
Figure 6-14: Molecular Diagnostics Instruments Market by Segment (%), 2012
Figure 7-1: MRI Equipment Market (Billion INR), 2012-2017
Figure 7-2: MRI Equipment Market by Segment (%), 2012
Figure 7-3: Ultrasound Equipment Market (Billion INR), 2012-2017
Figure 7-4: Ultrasound Equipment Market by Segment (%), 2012
Figure 7-5: X-ray Equipment Market (Billion INR), 2012-2017
Figure 7-6: X-ray Equipment Market by Segment (%), 2012
Figure 7-7: X-ray Equipments Market by Vertical (%), 2010
Figure 7-8: CT Scanners Market (Billion INR), 2012-2017
Figure 7-9: CT Scanners Market by Segment (%), 2012
Figure 7-10: Nuclear Imaging Equipment Market (Billion INR), 2012-2017
Figure 7-11: Nuclear Imaging Equipment Market by Segment (%), 2012
Figure 8-1: Lab Services Market (Billion INR), 2012-2017
Figure 8-2: Share of Pathology and Imaging Services in Lab Services Market (2012)
Figure 10-1: Roche - Share of Diagnostics in Total Revenue (2012)
Figure 10-2: Roche - Revenue Breakup of Diagnostics by Segment (%), 2012
Figure 10-3: Beckman Coulter - Share of Clinical Diagnostics in Total Revenue (2010)
Figure 10-4: Beckman Coulter - Revenue Breakup of Clinical Diagnostics by Segment (%), 2010
Figure 10-5: Abbott - Revenue Breakup by Business Division (%), 2012
Figure 10-6: Siemens - Revenue Breakup by Business Division (%), 2012
LIST OF TABLES:
Table 4-1: Prevalence of Obesity in Males and Females (%), 2005 & 2015
Table 4-2: HIV/AIDS Statistics
Table 4-3: Reported Cases of Communicable Diseases (2008)
Table 6-1: Biochemistry - Key Players and Products
Table 6-2: Hematology - Key Players and Products
Table 6-3: Immunochemistry - Key Players and Products
Table 6-4: Microbiology - Key Players and Products
Table 6-5: Coagulation - Key Players and Products
Table 6-6: Urinalysis - Key Players and Products
Table 6-7: Molecular Diagnostics - Key Players and Products
Table 7-1: MRI - Key Players and Products
Table 7-2: Ultrasound - Key Players and Products
Table 7-3: X-ray - Key Players and Products
Table 10-1: Roche - Key Financials (Million CHF), 2010-2012
Table 10-2: Beckman Coulter - Key Financials (Million US$), 2008-2010
Table 10-3: Abbott - Key Financials (Million US$), 2010-2012
Table 10-4: Siemens - Key Financials (Million Euro), 2010-2012
Table 4-1: Prevalence of Obesity in Males and Females (%), 2005 & 2015
Table 4-2: HIV/AIDS Statistics
Table 4-3: Reported Cases of Communicable Diseases (2008)
Table 6-1: Biochemistry - Key Players and Products
Table 6-2: Hematology - Key Players and Products
Table 6-3: Immunochemistry - Key Players and Products
Table 6-4: Microbiology - Key Players and Products
Table 6-5: Coagulation - Key Players and Products
Table 6-6: Urinalysis - Key Players and Products
Table 6-7: Molecular Diagnostics - Key Players and Products
Table 7-1: MRI - Key Players and Products
Table 7-2: Ultrasound - Key Players and Products
Table 7-3: X-ray - Key Players and Products
Table 10-1: Roche - Key Financials (Million CHF), 2010-2012
Table 10-2: Beckman Coulter - Key Financials (Million US$), 2008-2010
Table 10-3: Abbott - Key Financials (Million US$), 2010-2012
Table 10-4: Siemens - Key Financials (Million Euro), 2010-2012
